This inventor holds 1 USPTO granted patent. Top assignees: Axosim, Inc., University of Central Florida Research Foundation Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Lowry Curley: Innovator in 3D Microelectrode Arrays
Introduction
Lowry Curley is an accomplished inventor based in New Orleans, LA. He is known for his innovative contributions to the field of electrogenic cell research. His work focuses on the development of advanced technologies that enhance our understanding of cellular behavior.
Latest Patents
Curley's most notable patent is a 3D microelectrode array (MEA) designed for optical and electrical probing of electrogenic cells. This patent describes novel 3D microelectrode arrays that include a substrate body, microneedles, traces, and a well. The 3D MEA facilitates the transfer of electrical signals from one side of the substrate body to the other. Additionally, the patent outlines methods for using 3D MEAs to grow electrogenic cells and obtain electrophysiological signals. It also discloses fabrication techniques for producing these advanced microelectrode arrays. Curley holds 1 patent in this area.
Career Highlights
Throughout his career, Lowry Curley has worked with notable organizations, including the University of Central Florida Research Foundation Inc. and Axosim, Inc. His experience in these institutions has allowed him to contribute significantly to research and development in the field of bioengineering.
Collaborations
Curley has collaborated with talented individuals such as Corey Rountree and Avra Kundu. These partnerships have further enriched his research endeavors and have led to advancements in the technology surrounding electrogenic cells.
Conclusion
Lowry Curley's innovative work in the development of 3D microelectrode arrays has made a significant impact on the field of electrogenic cell research. His contributions continue to pave the way for future advancements in bioengineering and cellular studies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile